The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. (Q34455481)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. |
scientific article |
Statements
1 reference
The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2. (English)
1 reference
Yunyan Gu
Mengmeng Zhang
Lei Fang
Yuanyuan Zhang
Haihai Liang
Wenbin Zhou
Lu Ao
1 February 2015
1 reference
1 reference